Spectrum softgels offer convenience, are discreet, and provide consistent dosing. We have reduced the price of Yellow Softgels and, for a limited time, are offering a reduced price on all Red Softgels.

Spectrum softgels offer convenience, are discreet, and provide consistent dosing. We have reduced the price of Yellow Softgels and, for a limited time, are offering a reduced price on all Red Softgels.

Research

The Minor Cannabinoids in C. sativa

May 31, 2019 Spectrum Therapeutics

More than 100 cannabinoid molecules have been identified in cannabis. Our bodies naturally produce endocannabinoids and these interact with cannabinoid receptors in every organ system in our bodies. Many plants—most notably Cannabis sativa—also contain cannabinoids, such as THC and CBD.

The pharmacology of the two most prevalent cannabinoids, Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), has been well researched and most of the scientific and popular interest is focused on them. There are many other cannabinoids that are produced in trace amounts and, as a result, these have not received thorough investigation.

In addition to the pre-release testing we perform on all products—for THC and CBD concentrations, the absence of bacteria and fungi, and for pesticides—we perform additional tests, not required by Health Canada under the Cannabis Act. This provides healthcare professionals and their patients with extra information that can help them choose the products that are right for them.

Analytical tests

We analyze 12 minor cannabinoids and 21 terpenes that, while not required for standard lot release, are important for product profiling and investigating possible entourage effects. Here, we’ll discuss the minor cannabinoids.

Activation of cannabinoids

THC and CBD exist in the raw plant mostly as their precursors, Δ9‑tetrahydrocannabinolic acid (THCA) and cannabidiolic acid (CBDA). Inactive THCA and CBDA must be converted to the active forms (THC and CBD) that interact with the endocannabinoid system. Decarboxylation occurs naturally over time through light exposure and aging, but the simplest and fastest way to achieve this is by heating dried plant material, either by vapourizing or smoking. Thermal decarboxylation of the dried cannabis flowers is part of the production process of cannabis oils and softgels to ensure the cannabinoids in the finished product are activated and ready for oral consumption.

Secondary cannabinoids

Medical cannabis contains a number of secondary cannabinoids for which there is currently limited evidence about effects. Many are building blocks or breakdown products of the primary active components, THC and CBD. These have drawn the attention of researchers due to their interaction with the endocannabinoid system:

  • Tetrahydrocannabinolic acid (THCA)

  • Δ8-THC

  • Cannabidiolic acid (CBDA)

  • Cannabigerolic acid (CBGA)

  • Cannabigerol (CBG)

  • Cannabichromenic acid (CBCA)

  • Cannabichromene (CBC)

  • Cannabinol (CBN)

  • Cannabicyclol (CBL)

  • Tetrahydrocannabivarinic acid (THCVA)

  • Cannabidivarinic acid (CBDVA)

  • Cannabidivarin (CBDV)

This website uses cookies to recognize your computer or device to give you the best user experience and to improve its features. You can disable cookies through your browser but some features of the site will no longer be available. To read our Website Privacy Statement, click here.